Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B6,12 | Lung | Primary cancer | 3,515 | Tumor/Malignant | 91.4% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B6,13 | Lung | Primary cancer | 1,900 | Stromal | 54.1% | 0.91 | 0.28 |
| NSCLC_38242124__IMC__175_B6,14 | Lung | Primary cancer | 3,094 | Tumor/Malignant | 42.2% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B6,15 | Lung | Primary cancer | 2,936 | Tumor/Malignant | 56.8% | 0.92 | 0.25 |
| NSCLC_38242124__IMC__175_B6,16 | Lung | Primary cancer | 2,433 | Tumor/Malignant | 56.0% | 0.90 | 0.30 |
| NSCLC_38242124__IMC__175_B6,17 | Lung | Primary cancer | 3,239 | Stromal | 49.5% | 0.54 | 0.62 |
| NSCLC_38242124__IMC__175_B6,2 | Lung | Primary cancer | 2,696 | Tumor/Malignant | 65.6% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__175_B6,3 | Lung | Primary cancer | 3,549 | Tumor/Malignant | 66.7% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B6,4 | Lung | Primary cancer | 1,915 | Tumor/Malignant | 53.5% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__175_B6,5 | Lung | Primary cancer | 2,363 | Tumor/Malignant | 56.2% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__175_B6,6 | Lung | Primary cancer | 2,579 | Tumor/Malignant | 58.6% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B6,7 | Lung | Primary cancer | 3,749 | Tumor/Malignant | 50.7% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B6,8 | Lung | Primary cancer | 2,866 | Stromal | 45.7% | 0.87 | 0.41 |
| NSCLC_38242124__IMC__175_B6,9 | Lung | Primary cancer | 5,561 | Tumor/Malignant | 86.0% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__175_B7,1 | Lung | Primary cancer | 823 | Tumor/Malignant | 41.8% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__175_B7,10 | Lung | Primary cancer | 3,104 | Stromal | 55.5% | 0.89 | 0.33 |
| NSCLC_38242124__IMC__175_B7,11 | Lung | Primary cancer | 3,417 | Immune | 33.0% | 0.33 | 0.97 |
| NSCLC_38242124__IMC__175_B7,12 | Lung | Primary cancer | 3,705 | Tumor/Malignant | 78.9% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__175_B7,13 | Lung | Primary cancer | 3,302 | Tumor/Malignant | 27.2% | 0.73 | 0.57 |
| NSCLC_38242124__IMC__175_B7,14 | Lung | Primary cancer | 3,561 | Tumor/Malignant | 45.5% | 0.91 | 0.26 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B6,12 | Lung | Primary cancer | 3,515 | Tumor/Malignant | 82.4% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__175_B6,13 | Lung | Primary cancer | 1,900 | Stromal | 34.4% | 0.76 | 0.53 |
| NSCLC_38242124__IMC__175_B6,14 | Lung | Primary cancer | 3,094 | Tumor/Malignant | 42.1% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__175_B6,15 | Lung | Primary cancer | 2,936 | Tumor/Malignant | 32.9% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__175_B6,16 | Lung | Primary cancer | 2,433 | Tumor/Malignant | 46.0% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__175_B6,17 | Lung | Primary cancer | 3,239 | Tumor/Malignant | 40.2% | 0.78 | 0.54 |
| NSCLC_38242124__IMC__175_B6,2 | Lung | Primary cancer | 2,696 | Tumor/Malignant | 41.5% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_B6,3 | Lung | Primary cancer | 3,549 | Tumor/Malignant | 67.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_B6,4 | Lung | Primary cancer | 1,915 | Tumor/Malignant | 35.8% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__175_B6,5 | Lung | Primary cancer | 2,363 | Tumor/Malignant | 35.4% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__175_B6,6 | Lung | Primary cancer | 2,579 | Tumor/Malignant | 59.1% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B6,7 | Lung | Primary cancer | 3,749 | Tumor/Malignant | 47.5% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__175_B6,8 | Lung | Primary cancer | 2,866 | Stromal | 41.0% | 0.90 | 0.37 |
| NSCLC_38242124__IMC__175_B6,9 | Lung | Primary cancer | 5,561 | Tumor/Malignant | 76.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B7,1 | Lung | Primary cancer | 823 | Tumor/Malignant | 38.3% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__175_B7,10 | Lung | Primary cancer | 3,104 | Stromal | 42.3% | 0.74 | 0.54 |
| NSCLC_38242124__IMC__175_B7,11 | Lung | Primary cancer | 3,417 | Stromal | 29.6% | 0.72 | 0.65 |
| NSCLC_38242124__IMC__175_B7,12 | Lung | Primary cancer | 3,705 | Tumor/Malignant | 67.7% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__175_B7,13 | Lung | Primary cancer | 3,302 | Tumor/Malignant | 27.3% | 0.97 | 0.15 |
| NSCLC_38242124__IMC__175_B7,14 | Lung | Primary cancer | 3,561 | Tumor/Malignant | 41.8% | 0.92 | 0.21 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B6,12 | Lung | Primary cancer | 3,515 | Tumor/Malignant cell | 70.5% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__175_B6,13 | Lung | Primary cancer | 1,900 | Fibroblast | 56.9% | 0.89 | 0.32 |
| NSCLC_38242124__IMC__175_B6,14 | Lung | Primary cancer | 3,094 | Tumor/Malignant cell | 42.3% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B6,15 | Lung | Primary cancer | 2,936 | Tumor/Malignant cell | 56.1% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__175_B6,16 | Lung | Primary cancer | 2,433 | Tumor/Malignant cell | 56.4% | 0.90 | 0.30 |
| NSCLC_38242124__IMC__175_B6,17 | Lung | Primary cancer | 3,239 | Fibroblast | 46.4% | 0.45 | 0.77 |
| NSCLC_38242124__IMC__175_B6,2 | Lung | Primary cancer | 2,696 | Tumor/Malignant cell | 65.6% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__175_B6,3 | Lung | Primary cancer | 3,549 | Tumor/Malignant cell | 77.9% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__175_B6,4 | Lung | Primary cancer | 1,915 | Tumor/Malignant cell | 52.7% | 0.97 | 0.18 |
| NSCLC_38242124__IMC__175_B6,5 | Lung | Primary cancer | 2,363 | Tumor/Malignant cell | 55.4% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__175_B6,6 | Lung | Primary cancer | 2,579 | Tumor/Malignant cell | 58.7% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B6,7 | Lung | Primary cancer | 3,749 | Tumor/Malignant cell | 55.1% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__175_B6,8 | Lung | Primary cancer | 2,866 | Fibroblast | 40.1% | 0.85 | 0.45 |
| NSCLC_38242124__IMC__175_B6,9 | Lung | Primary cancer | 5,561 | Tumor/Malignant cell | 81.1% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__175_B7,1 | Lung | Primary cancer | 823 | Tumor/Malignant cell | 41.7% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__175_B7,10 | Lung | Primary cancer | 3,104 | Fibroblast | 42.2% | 0.87 | 0.38 |
| NSCLC_38242124__IMC__175_B7,11 | Lung | Primary cancer | 3,417 | Fibroblast | 33.0% | 0.68 | 0.74 |
| NSCLC_38242124__IMC__175_B7,12 | Lung | Primary cancer | 3,705 | Tumor/Malignant cell | 83.4% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_B7,13 | Lung | Primary cancer | 3,302 | Tumor/Malignant cell | 28.2% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_B7,14 | Lung | Primary cancer | 3,561 | Tumor/Malignant cell | 45.7% | 0.91 | 0.26 |